Smoking and Age-Related Macular Degeneration

Current smokers face approximately double the risk of developing AMD compared to non-smokers. This association is dose-dependent, meaning the more pack-years of smoking a person accumulates, the greater their risk. Even light smoking raises risk above the non-smoker baseline, and there is no amount of smoking that is considered safe for the macula.

The good news is that quitting smoking leads to meaningful risk reduction over time. People who quit smoking about 20 years ago have been found to have AMD risk comparable to those who never smoked at all. Risk reduction begins as soon as you quit and continues to improve over the following years and decades. The sooner you stop, the more years of reduced risk you gain.

Even after quitting, former smokers carry a higher-than-average AMD risk for many years. The oxidative damage to retinal tissue does not reverse immediately. This is why regular dilated eye exams are especially important for former smokers. Catching AMD early, while it is still in its intermediate stage, gives our eye doctors the best opportunity to help slow its progression.

The long-term retinal effects of e-cigarettes and vaping products are not yet well understood, as the technology is still relatively new. However, nicotine and other chemicals found in vaping products may pose similar vascular risks to the retina as traditional cigarettes. The safest approach for your macular health is to avoid all nicotine and tobacco products, including e-cigarettes.

Secondhand smoke exposes your eyes to many of the same toxic compounds as direct smoking, though typically at lower concentrations. If you have AMD or are at elevated risk, reducing your exposure to secondhand smoke is a reasonable and worthwhile step. This may mean spending less time in environments where smoking occurs regularly.

Quitting smoking does not reverse damage that has already occurred in the macula. The benefit is protective rather than restorative, meaning it slows further deterioration and reduces your risk of advancing to a more severe stage. While it will not undo existing vision loss, it can make a meaningful difference in how quickly the disease progresses from this point forward.

Yes, continued smoking can reduce how effectively AMD treatments work. Ongoing oxidative damage from smoking works against the benefit of treatments like anti-VEGF injections, which are used for wet AMD. Quitting supports the effectiveness of any AMD treatment you receive and allows your body to respond more fully to those therapies.

Having a parent with AMD means you carry a genetic risk factor for the disease, regardless of your own smoking habits. Not smoking significantly reduces your modifiable risk, and that is within your control. It is important to tell our eye doctors about your family history so they can recommend appropriate screening intervals and monitor you more closely for early signs of AMD.

Absolutely. Quitting at any stage of AMD is beneficial because it reduces the rate of progression to more advanced disease. For patients with intermediate AMD, slowing progression to advanced AMD is a meaningful and achievable goal, and quitting smoking is one of the most powerful ways to support that goal alongside AREDS2 supplementation and regular monitoring.